The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stamou, P.
Right arrow Articles by Stockinger, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stamou, P.
Right arrow Articles by Stockinger, B.
The Journal of Immunology, 2003, 171: 1278-1284.
Copyright © 2003 by The American Association of Immunologists

Chronic Exposure to Low Levels of Antigen in the Periphery Causes Reversible Functional Impairment Correlating with Changes in CD5 Levels in Monoclonal CD8 T Cells

Panagiota Stamou*, James de Jersey*, Danielle Carmignac{dagger}, Clio Mamalaki{ddagger}, Dimitris Kioussis* and Brigitta Stockinger1,*

Divisions of * Molecular Immunology and {dagger} Molecular Neuroendocrinology, The National Institute for Medical Research, London, United Kingdom; and {ddagger} Institute for Molecular Biology and Biotechnology-Foundation for Research and Technology, Hellas, Heraklion, Greece

This study describes a double-transgenic model in which monoclonal CD8 F5 T cells are chronically exposed to self Ag (nucleoprotein) in the periphery, but are not affected during thymic development. Chronic exposure of CD8 T cells to their cognate Ag rendered them unable to proliferate or produce cytokines in response to antigenic stimulation in vitro. However, the cells still retained some killer function in vivo and continuously eliminated APC expressing high levels of Ag. In addition, when crossed with mice expressing Ag in the anterior pituitary gland (triple-transgenic mice), F5 T cells migrated to this site and killed growth hormone producing somatotrophs. The anergic state was reversible upon transfer into Ag-free recipients, resulting in full recovery of in vitro responsiveness to Ag. Anergic CD8 T cells express higher levels of CD5, a negative regulator of T cell signaling, whereas after transfer and residence in Ag-free hosts, CD5 levels returned to normal. This suggests that up-regulation of negative T cell regulators in peripheral T cells exposed to chronic stimulation by Ag may prevent full functionality and thus avoid overt autoreactivity.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Vera, R. Fenutria, O. Canadas, M. Figueras, R. Mota, M.-R. Sarrias, D. L. Williams, C. Casals, J. Yelamos, and F. Lozano
From the Cover: The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndrome
PNAS, February 3, 2009; 106(5): 1506 - 1511.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. C. Formenti and S. Demaria
Effects of Chemoradiation on Tumor-Host Interactions: The Immunologic Side
J. Clin. Oncol., March 20, 2008; 26(9): 1562 - 1563.
[Full Text] [PDF]


Home page
BloodHome page
T. J. Kenna, R. Thomas, and R. J. Steptoe
Steady-state dendritic cells expressing cognate antigen terminate memory CD8+ T-cell responses
Blood, February 15, 2008; 111(4): 2091 - 2100.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. L. Rankin, A. J. Reed, S. Oh, C. Cozzo Picca, H. M. Guay, J. Larkin III, L. Panarey, M. K. Aitken, B. Koeberlein, P. E. Lipsky, et al.
CD4+ T Cells Recognizing a Single Self-Peptide Expressed by APCs Induce Spontaneous Autoimmune Arthritis
J. Immunol., January 15, 2008; 180(2): 833 - 841.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. M. Ashour and T. M. Seif
The role of B cells in the induction of peripheral T cell tolerance
J. Leukoc. Biol., November 1, 2007; 82(5): 1033 - 1039.
[Full Text] [PDF]


Home page
J. Immunol.Home page
I. Chatzidakis, G. Fousteri, D. Tsoukatou, G. Kollias, and C. Mamalaki
An Essential Role for TNF in Modulating Thresholds for Survival, Activation, and Tolerance of CD8+ T Cells
J. Immunol., June 1, 2007; 178(11): 6735 - 6745.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. J. Steptoe, J. M. Ritchie, N. S. Wilson, J. A. Villadangos, A. M. Lew, and L. C. Harrison
Cognate CD4+ Help Elicited by Resting Dendritic Cells Does Not Impair the Induction of Peripheral Tolerance in CD8+ T Cells
J. Immunol., February 15, 2007; 178(4): 2094 - 2103.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A. Boesteanu, A. L. Rankin, and A. J. Caton
Impact of effector cell differentiation on CD4+ T cells that evade negative selection by a self-peptide
Int. Immunol., July 1, 2006; 18(7): 1017 - 1027.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Raimondi, I. Zanoni, S. Citterio, P. Ricciardi-Castagnoli, and F. Granucci
Induction of Peripheral T Cell Tolerance by Antigen-Presenting B Cells. II. Chronic Antigen Presentation Overrules Antigen-Presenting B Cell Activation
J. Immunol., April 1, 2006; 176(7): 4021 - 4028.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Chiodetti, S. Choi, D. L. Barber, and R. H. Schwartz
Adaptive Tolerance and Clonal Anergy Are Distinct Biochemical States
J. Immunol., February 15, 2006; 176(4): 2279 - 2291.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Dorothee, I. Vergnon, F. El Hage, B. L. M. Chansac, V. Ferrand, Y. Lecluse, P. Opolon, S. Chouaib, G. Bismuth, and F. Mami-Chouaib
In Situ Sensory Adaptation of Tumor-Infiltrating T Lymphocytes to Peptide-MHC Levels Elicits Strong Antitumor Reactivity
J. Immunol., June 1, 2005; 174(11): 6888 - 6897.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Andris, S. Denanglaire, F. de Mattia, J. Urbain, and O. Leo
Naive T Cells Are Resistant to Anergy Induction by Anti-CD3 Antibodies
J. Immunol., September 1, 2004; 173(5): 3201 - 3208.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Th. den Boer, G. J. D. van Mierlo, M. F. Fransen, C. J. M. Melief, R. Offringa, and R. E. M. Toes
The Tumoricidal Activity of Memory CD8+ T Cells Is Hampered by Persistent Systemic Antigen, but Full Functional Capacity Is Regained in an Antigen-Free Environment
J. Immunol., May 15, 2004; 172(10): 6074 - 6079.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.